Trials / Conditions / Plaque-type Psoriasis

Plaque-type Psoriasis

14 registered clinical trials studyying Plaque-type Psoriasis.

Status	Trial	Sponsor	Phase
Completed	MSB11022 in Moderate to Severe Chronic Plaque Psoriasis NCT02660580	Fresenius Kabi SwissBioSim GmbH	Phase 3
Completed	Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira NCT02016105	Sandoz	Phase 3
Withdrawn	A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate NCT01936688	Sun Pharmaceutical Industries Limited	Phase 3
Completed	Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating NCT01636687	Novartis Pharmaceuticals	Phase 3
Completed	SHP-141C in Plaque Type Psoriasis NCT01646567	TetraLogic Pharmaceuticals	Phase 1
Completed	Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psor NCT01412944	Novartis Pharmaceuticals	Phase 3
Completed	Safety Study of Ointment for the Treatment of Plaque-type Psoriasis NCT01258088	Pfizer	Phase 1
Completed	AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis NCT01132612	Novartis Pharmaceuticals	Phase 2
Completed	A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoria NCT00852761	Stiefel, a GSK Company	Phase 4
Completed	Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis ( NCT00773734	Amgen	Phase 2
Completed	Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis NCT00763503	Galderma R&D	Phase 2
Completed	Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis NCT00625326	Deltanoid Pharmaceuticals	Phase 2
Completed	Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis NCT00521339	Amgen	Phase 2
Completed	n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis NCT01876875	Federico II University	Phase 4